BioSpace News Archive

APX3330 Phase I Oncology Trial Presented at AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Meeting

Apexian Pharmaceuticals, Inc., a clinical-stage drug development company focused on advancing APX3330 for the treatment of diseases mediated by the APE1/Ref-1 protein, presented additional data on their Phase 1 study using APX3330 in patients with advanced solid tumors.

October 29, 2019
·
1 min read
Deals

Sense Biodetection Raises £12.3m to Progress Instrument-Free Molecular Diagnostics

Initial focus on diagnosing infectious disease through development of machine-free, lab-quality, True Point-of-Care™ products

October 29, 2019
·
4 min read
Deals

Earlybird Co-leads Investment In Instrument-free Molecular Diagnostics Company Sense Biodetection

Sense Biodetection Limited raises £12.3m to progress instrument-free molecular diagnostics

October 29, 2019
·
4 min read
CPhI Annual Report predicts Europe to surpass the USA in biologic manufacturing capacity by 2023

Demand for biological manufacturing is growing faster than capacity growth, and Emil Ciurczak forewarns the need for tighter quality controls in biosimilars production.

October 29, 2019
·
9 min read
Octapharma Adopts Genedata Bioprocess to Develop Next-generation Bio-manufacturing Processes

Leading manufacturer of therapeutic proteins implements Genedata Bioprocess to streamline development and manufacture of biopharmaceuticals

October 29, 2019
·
4 min read
Drug Development

Mirati’s KRAS Inhibitor Promising in Early-Stage Trial of Solid Tumors

San Diego-based Mirati Therapeutics announced the first clinical data from its Phase I/II clinical trial of MRTX849 in solid tumors. MRTX849 is a KRAS G12C inhibitor.

October 29, 2019
·
2 min read
·
Mark Terry
Business

Gotham Therapeutics Establishes Advanced Oncology Profiling Cascade with ProQinase to Progress its Portfolio of Epitranscriptomic Drug Candidates

Gotham’s pipeline covers the entire reader-writer-eraser paradigm with three lead programs advancing in parallel through preclinical discovery

October 29, 2019
·
3 min read
Business

Mobidiag Signs New International Agreements for Distribution of its Amplidiag® and Novodiag® Diagnostic Solutions

Agreements signed in Poland, Ukraine, Romania and Israel, with more in discussions.

October 29, 2019
·
4 min read
Drug Development

Vapogenix Reports Encouraging Phase II Results of Topical Non-Opioid Pain Medication

Vapogenix announced results of a Phase II clinical trial of its lead product, VPX638, which demonstrate rapid onset and sustained duration of pain relief and reduced opioid use for patients with painful wounds.

October 29, 2019
·
4 min read
Business

Pfizer Reports Third-Quarter 2019 Results

Pfizer Inc. reported financial results for third-quarter 2019 and updated certain components of its 2019 financial guidance..

October 29, 2019
·
53 min read